Shares

10 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Jan 31, 2022

SELL
N/A
-86,700 Closed
0 $0
Q1 2020

Apr 16, 2020

SELL
N/A
-33,529 Reduced 27.89%
86,700 $388,000
Q4 2019

Feb 05, 2020

SELL
N/A
-204,750 Reduced 63.0%
120,229 $705,000
Q3 2019

Oct 23, 2019

SELL
N/A
-45,000 Reduced 12.16%
324,979 $1.83 Million
Q1 2019

Apr 23, 2019

SELL
N/A
-971 Reduced 0.26%
369,979 $2.03 Million
Q4 2018

Jan 23, 2019

SELL
N/A
-10,000 Reduced 2.63%
370,950 $2.12 Million
Q3 2018

Oct 24, 2018

SELL
N/A
-22,750 Reduced 5.64%
380,950 $2.41 Million
Q2 2018

Jul 10, 2018

SELL
N/A
-5,000 Reduced 1.22%
403,700 $2.48 Million
Q4 2017

Feb 09, 2018

SELL
N/A
-5,400 Reduced 1.3%
408,700 $2.66 Billion
Q2 2017

Aug 10, 2017

BUY
N/A
414,100
414,100 $3.29 Billion

About Knight Therapeutics Inc.


  • Ticker GUD.TO
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 114,623,000
  • Market Cap $628M
More about GUD.TO
Track This Portfolio

Track Account Management LLC Portfolio

Follow Account Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Account Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Account Management LLC with notifications on news.